Showing results (2091-2100 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 3, 2012
Antimycobacterial activity of quaternary pyridinium salts and pyridinium N-oxides--reviewMartin Krátký, Jarmila VinšováCurrent Pharmaceutical Design|November 3, 2012
Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexesMandy H M Leung, Takaaki Harada, Tak W KeeCurrent Pharmaceutical Design|November 3, 2012
D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapySilvia Sacchi, Elena Rosini, Loredano Pollegioni, et al.Current Pharmaceutical Design|November 3, 2012
Targeting UDP-galactopyranose mutases from eukaryotic human pathogensKarina Kizjakina, John J Tanner, Pablo SobradoCurrent Pharmaceutical Design|November 3, 2012
The oxido-reductase activity of the apoptosis inducing factor: a promising pharmacological tool?Patricia Ferreira, Raquel Villanueva, Lauriane Cabon, et al.Current Pharmaceutical Design|November 3, 2012
The prokaryotic FAD synthetase family: a potential drug targetAna Serrano, Patricia Ferreira, Marta Martínez-Júlvez, et al.Current Pharmaceutical Design|November 3, 2012
1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agentsDidier Belorgey, Don Antoine Lanfranchi, Elisabeth Davioud-CharvetCurrent Pharmaceutical Design|October 25, 2012
Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusionYuxian HeCurrent Pharmaceutical Design|October 25, 2012
Inhibitors of HIV-1 entryEwa D Micewicz, Piotr RuchalaCurrent Pharmaceutical Design|October 25, 2012
Molecular aspects of the RT/drug interactions. Perspective of dual inhibitorsSimona Distinto, Elias Maccioni, Rita Meleddu, et al.Pageof 1,008